# Post ts_115946969213492152 - Post ID: `ts_115946969213492152` - Platform: Truth Social - Posted: 2026-01-23T23:19:05.708Z (UTC) - Deleted: no - Repost: no - Canonical URL: https://trump.fm/post/ts_115946969213492152 - Analysis page: https://trump.fm/post/ts_115946969213492152/analysis - Audio narration: https://static.trump.fm/audio/ts_115946969213492152.mp3 (a synthesized voice reading the post text, not a recording) ## Post text > U.S., U.K. Strike Deal on Higher Drug Prices: Move marks victory for Trump administration campaign to get other countries to pay more for drugs: https://www.wsj.com/health/pharma/u-s-u-k-strike-deal-on-higher-drug-prices-a507f83c ## Engagement - Likes: 12,969 - Reposts: 3,062 - Replies: 307 - Views: unknown - Metrics collected: 2026-02-01T01:19:51.284Z (UTC) # Analysis _Machine-generated by trump.fm on 2026-03-22T07:12:46.999Z (UTC): a model's reading of this post, not his words. Its psychological terms describe the language, not a clinical assessment of him._ ## Analysis: WSJ Drug Pricing Deal Share This post is a straightforward share of a Wall Street Journal article about a U.S.-U.K. deal on drug pricing, framed as a Trump administration victory. It is minimally editorialized — the text is essentially the article headline and subheadline with a link. ### Authorship This is almost certainly aide-written (likely Scavino or comms staff). The post is a clean copy-paste of the WSJ headline and subtitle with a link. No personal commentary, no emotional language, no ALL CAPS, no typos. Trump was traveling to/from Davos on this date; the UTC timestamp (23:19) corresponds to ~6:19 PM EST, squarely in business hours. The format is consistent with standard comms-team news amplification. ### Psychological Analysis Minimal psychological content to analyze. The post serves a **supply-seeking** function — amplifying a favorable news story to reinforce the narrative of policy success. The framing positions Trump as achieving something other presidents couldn't: forcing allied nations to pay more for pharmaceuticals. This is consistent with the **dealmaker protagonist** role and **agency/power motives**. ### Rhetorical Techniques The WSJ headline itself does the rhetorical work — "victory for Trump administration" is the key phrase. By sharing it without editorializing, the post lets a prestigious source validate the administration's narrative, which is more persuasive than self-praise. ### Context This post sits within a day dominated by aide-written congressional endorsements and policy amplification, consistent with a day when Trump was traveling internationally (Davos) and staff managed the social media presence. ## Fact Verification | Claim | Verdict | Evidence | |-------|---------|----------| | "U.S. and U.K. struck a deal on higher drug prices" | **True** | This claim is confirmed by extensive official and independent sources. On December 1, 2025, the Office of the United States Trade Representative, the Department of Commerce, and the Department of Health and Human Services jointly announced an "agreement in principle" with the United Kingdom on pharmaceutical pricing. The UK government simultaneously issued its own press release confirming the deal. Specific terms of the agreement: (1) The UK committed to increasing net prices paid for new medicines by 25%, the first such increase in over 20 years. (2) NICE cost-effectiveness thresholds would rise from 20,000-30,000 GBP per quality-adjusted life year to 25,000-35,000 GBP. (3) The voluntary rebate scheme rate would decrease from 23.5% to a capped 15% in 2026. (4) In exchange, the U.S. exempted UK-origin pharmaceuticals, pharmaceutical ingredients, and medical technology from Section 232 tariffs and committed to not targeting UK pharmaceutical pricing in future Section 301 investigations during Trump's term. The deal built on the broader UK-US Economic Prosperity Deal signed in May 2025 between Trump and Prime Minister Starmer. Key U.S. officials involved included Ambassador Jamieson Greer (USTR), Secretary Howard Lutnick (Commerce), and HHS Secretary Robert F. Kennedy Jr. UK Science Secretary Liz Kendall promoted the agreement on the British side. The characterization as a "victory for Trump administration campaign to get other countries to pay more for drugs" (from the WSJ subtitle) is editorially framed but substantively accurate — the deal was explicitly part of the administration's "most favored nation" pricing strategy, and the White House subsequently pursued similar deals with other countries. Critics, including University of York health economist James Lomas, questioned whether higher UK prices would actually translate to lower American drug prices, but the existence and basic terms of the deal itself are not in dispute. Confirmed by: official USTR and UK government press releases, STAT News, Al Jazeera, BioPharma Dive, Chemistry World, American Hospital Association, MedCity News, NHS Confederation, and legal analyses from Morgan Lewis, Sidley Austin, and Hogan Lovells. | Overall Veracity: 100% ## Authorship Analysis **Aide-Written** (score: 10%) ### Indicators - Clean copy-paste of WSJ headline/subtitle - No personal commentary or emotional language - No ALL CAPS or typos - Business hours posting (6:19 PM EST) - Trump traveling internationally (Davos) ## Psychological Profile ### State **Grandiose State** **Trigger:** Supply Seeking (WSJ favorable coverage) Sentiment: +0.50 ### Clinical **Malignant Narcissism:** - Narcissistic: 30% - Antisocial: 0% - Paranoid: 0% - Sadism: 0% **Cognitive Complexity:** - Complexity: 30% **Parasocial Techniques:** - third-party validation ## Fact Checks (1) _The model's verdicts from 2026-03-22; a recheck of the unverifiable ones last ran 2026-03-29._ > U.S. and U.K. struck a deal on higher drug prices **TRUE** This claim is confirmed by extensive official and independent sources. On December 1, 2025, the Office of the United States Trade Representative, the Department of Commerce, and the Department of Health and Human Services jointly announced an "agreement in principle" with the United Kingdom on pharmaceutical pricing. The UK government simultaneously issued its own press release confirming the deal. Specific terms of the agreement: (1) The UK committed to increasing net prices paid for new medicines by 25%, the first such increase in over 20 years. (2) NICE cost-effectiveness thresholds would rise from 20,000-30,000 GBP per quality-adjusted life year to 25,000-35,000 GBP. (3) The voluntary rebate scheme rate would decrease from 23.5% to a capped 15% in 2026. (4) In exchange, the U.S. exempted UK-origin pharmaceuticals, pharmaceutical ingredients, and medical technology from Section 232 tariffs and committed to not targeting UK pharmaceutical pricing in future Section 301 investigations during Trump's term. The deal built on the broader UK-US Economic Prosperity Deal signed in May 2025 between Trump and Prime Minister Starmer. Key U.S. officials involved included Ambassador Jamieson Greer (USTR), Secretary Howard Lutnick (Commerce), and HHS Secretary Robert F. Kennedy Jr. UK Science Secretary Liz Kendall promoted the agreement on the British side. The characterization as a "victory for Trump administration campaign to get other countries to pay more for drugs" (from the WSJ subtitle) is editorially framed but substantively accurate — the deal was explicitly part of the administration's "most favored nation" pricing strategy, and the White House subsequently pursued similar deals with other countries. Critics, including University of York health economist James Lomas, questioned whether higher UK prices would actually translate to lower American drug prices, but the existence and basic terms of the deal itself are not in dispute. Confirmed by: official USTR and UK government press releases, STAT News, Al Jazeera, BioPharma Dive, Chemistry World, American Hospital Association, MedCity News, NHS Confederation, and legal analyses from Morgan Lewis, Sidley Austin, and Hogan Lovells. Sources: https://ustr.gov/about/policy-offices/press-office/press-releases/2025/december/us-government-announces-agreement-principle-united-kingdom-pharmaceutical-pricing; https://www.gov.uk/government/news/landmark-uk-us-pharmaceuticals-deal-to-safeguard-medicines-access-and-drive-vital-investmentfor-uk-patients-and-businesses; https://www.commerce.gov/news/press-releases/2025/12/us-government-announces-agreement-principle-united-kingdom; https://www.statnews.com/2025/12/01/uk-us-pharma-deal-payments/; https://www.aljazeera.com/economy/2025/12/1/us-uk-agree-to-zero-tariffs-on-medicines-uk-commits-to-higher-spending; https://www.biopharmadive.com/news/us-uk-drug-price-deal-pharmaceuticals-tariffs/806662/; https://www.chemistryworld.com/news/uk-agrees-higher-drug-prices-to-secure-zero-tariff-deal-with-us/4022658.article; https://www.aha.org/news/headline/2025-12-02-us-reaches-trade-agreement-uk-drug-pricing; https://medcitynews.com/2025/12/drug-prices-pharmaceutical-tariff-us-uk-trade-deal-trump-nhs-nice/; https://www.morganlewis.com/pubs/2025/12/uk-us-pharmaceutical-trade-deal-impact-on-uk-drug-pricing-tariffs-and-investment; https://www.sidley.com/en/insights/newsupdates/2025/12/us-and-uk-announce-agreement-exempting-uk-origin-pharmaceuticals-from-tariffs; https://www.nhsconfed.org/publications/changes-medicines-policy-what-you-need-know; https://www.hoganlovells.com/en/publications/milestone-usuk-drug-tariff-and-pricing-deal-announced Overall Veracity: 100% ## Tags - policy-amplification (100%) - aide-written (90%) - trade-deal (80%) ## That day _From trump.fm's machine-generated digest of the day, not his words._ **Home from Davos, a four-hour burst of grievance gives way to an assembly line of endorsements — and total silence on the 50,000 marching against him** Trump flew home from Davos and posted 81 times across the day, but the day split cleanly in two. The evening hours coming off the plane produced a tight burst of personal attacks — an Indiana state senator who crossed him on redistricting, Gavin Newsom for attending the same conference he'd just attended, the Fed chair, Canada's prime minister, and a call to jail his former prosecutor — all within about four hours. After a short night's sleep, the rest of the day was almost entirely flat: link-drops, trade and peace-deal victory laps, and an assembly line of more than twenty near-identical congressional endorsements fired off at roughly one every forty-five seconds. He mocked climate scientists over a record cold wave in the morning and issued a serious FEMA storm warning about the same weather system eleven hours later. Most notably, he said nothing at all about the 50,000-person general strike in Minneapolis against his own immigration crackdown. Full digest for 2026-01-23: https://trump.fm/date/2026-01-23/analysis ## Citation - APA: Trump, D. J. (2026, January 23). U.S., U.K. Strike Deal on Higher Drug Prices:... [Social media post]. Truth Social. trump.fm. https://trump.fm/post/ts_115946969213492152 - MLA: Trump, Donald J. "U.S., U.K. Strike Deal on Higher Drug Prices: Move marks..." Truth Social, 23 Jan. 2026. trump.fm, https://trump.fm/post/ts_115946969213492152. Accessed 9 Oct. 2026. - Chicago: Donald J. Trump, "U.S., U.K. Strike Deal on Higher Drug Prices: Move marks...," Truth Social, January 23, 2026, archived at trump.fm, https://trump.fm/post/ts_115946969213492152. ## For agents - Site overview: https://trump.fm/llms.txt - API specification: https://trump.fm/openapi.json - MCP server: https://trump.fm/mcp (search and fetch tools, no auth) - This post as JSON: https://trump.fm/api/posts/ts_115946969213492152 - Analysis as JSON: https://trump.fm/api/analysis/ts_115946969213492152 - All citation formats: https://trump.fm/api/cite/ts_115946969213492152 - Same day: https://trump.fm/date/2026-01-23 - The record alone, without the analysis: https://trump.fm/post/ts_115946969213492152.md?analysis=false _Markdown view of a trump.fm page. Post, analysis, date, feed, contradictions, search and about pages answer in markdown at their URL with `.md` appended (`/index.md` for the home page), or when sent `Accept: text/markdown`._